S.E.A. Medical Secures $3 Million in Series B Financing from JK&B Capital

SANTA CLARA, Calif.–S.E.A. Medical Systems Inc., a healthtech company focused on safety and management of IV medicine, today announced that it closed a $3 million Series B investment with Chicago-based venture capital firm JK&B Capital, which specializes in investments in Information Technologies,...

Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma

KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received guidance from the U.S. Food and Drug Administration (“FDA”) to submit its Phase 3 protocol for...

This Week In Diagnostics

Clinical trial initiated for Trisomy 21 test Aria Diagnostics (formerly Tandem Diagnostics) says that it is initiating a multicenter clinical trial that compares its non-invasive prenatal test with the standard first-trimester screening test (serum screening and nuchal translucency ultrasound alone and in...

Miracor Aims to Cure More Than 350K Broken Hearts Per Year with New PCI Intervention System

Miracor Medical Systems is a privately held medical technology company based in Vienna, Austria and is aiming to help patients who have experienced cardiac surgery or suffer from acute coronary syndrome (ACS) improve their quality of life. Their main technology is called the PISCO® (Pressure-Controlled...

Biocept, Inc. Making Advances in Circulating Tumor Cell Research for Cancers

Biocept Inc. is a privately held laboratory testing company based in San Diego, Calif. focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients. Their most recent project was documented in a paper published in the December 2011 issue of Cancer Discovery. The paper showcased...

Microvisk Limited Uses Same Technology as iPhone, Wii to Measure Blood Coagulation

Microvisk Limited is a UK-based medical technology company focused on developing medical testing devices based on micro electro medical sensors (MEMS) for the international healthcare market. The company is owned by private and venture capital investors including Porton Capital, Oxford Technology Management,...